Tom Phillips
Key details
- Title: Group Editor
- Email:tphillips@lifesciencesipreview.com
- Telephone: +44 (0)20 330 18210
With more than 20 years of experience in business and legal journalism, Tom Phillips is a leading editor, webinar host, and conference moderator in the intellectual property law industry.
He regularly appears on the WIPR Insights webinar channel, writes frequently on issues affecting in-house IP counsel, and attends IP conferences around the world.
Total results: 43
Articles by Tom Phillips
Americas
Well-drafted contracts and ironclad tech security can save time and money when an ex-employee steals IP ‘like sugar packets in Starbucks’, finds Tom Phillips. 7 November 2024
Careers
US firm doubles down in Europe with another big name recruit | Tech and life sciences litigation at the UPC a target | Powell will 'always be a friend of the firm’ says ex-colleague Penny Gilbert | Move ends speculation about Powell’s future after August resignation. 14 October 2024
Unified Patent Court
The president of the appeals court reveals his thinking on transparency, bringing more countries on board, and the hidden delays in the EU Commission’s SEP plan. 24 September 2024
Europe
Double promotion includes patent attorney who challenged Novartis in G1/22 | Supplementary Protection Certificates expert also joins partnership. 2 July 2024
Careers
Star litigator moves firms with nearly a dozen attorneys | Biologic drug patent and Hatch-Waxman patent expert David Hanna also joins. 7 May 2024
Careers
Ex-head of Kramer Levin life sciences practice leaves for new firm | 20 years of experience includes numerous multi-billion dollar cases for some of the world’s best-selling drugs. 16 April 2024
Careers
Firm hires former Food and Drug Administration staffer from King & Spalding | Washington DC office gains nearly a decade of FDA experience. 5 March 2024
Biotech
Biotech firm agrees licence deal days after its gene editing treatment gets landmark FDA approval | Patents owned by the Broad Institute protect technology sold via Editas Medicines. 14 December 2023
Biotech
Leader of Brown Rudnik’s IP practice moves to US office of London firm | Boston office continues growth. 12 January 2023
Pharma
Pharma giant Novartis has filed a patent suit against Crystal Pharmaceuticals after the rival sought to create a generic version of its heart failure drug Entresto. 30 September 2021
Not finding what you're looking for, please try resetting your applied search and filters,
or try the full site search.